Stay updated on Guselkumab vs Ustekinumab in Psoriasis Clinical Trial

Sign up to get notified when there's something new on the Guselkumab vs Ustekinumab in Psoriasis Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Guselkumab vs Ustekinumab in Psoriasis Clinical Trial page

  1. Check
    7 days ago
    Change Detected
    Summary
    Revision updated from v3.3.3 to v3.3.4. No substantive content changes are visible in the screenshot; this appears to be a backend version update.
    Difference
    0.0%
    Check dated 2026-01-14T02:44:41.000Z thumbnail image
  2. Check
    14 days ago
    No Change Detected
  3. Check
    21 days ago
    No Change Detected
  4. Check
    28 days ago
    Change Detected
    Summary
    Added a comprehensive Locations section listing study sites across US states and Canadian provinces; removed prior location subsections and the HHS Vulnerability Disclosure as part of a revision.
    Difference
    2%
    Check dated 2025-12-23T17:16:47.000Z thumbnail image
  5. Check
    57 days ago
    Change Detected
    Summary
    Added a note that publications are automatically filled from PubMed and may not all be about the study. Revision updated to version v3.3.2.
    Difference
    0.1%
    Check dated 2025-11-24T21:31:11.000Z thumbnail image
  6. Check
    64 days ago
    Change Detected
    Summary
    The top government funding/operating status notice was removed from the page.
    Difference
    0.2%
    Check dated 2025-11-17T19:55:47.000Z thumbnail image
  7. Check
    71 days ago
    Change Detected
    Summary
    Tainan City, Taiwan was removed and Tainan, Taiwan was added to the study locations. This aligns site naming with current common usage and improves accuracy for participants seeking nearby sites.
    Difference
    0.0%
    Check dated 2025-11-10T17:29:46.000Z thumbnail image
  8. Check
    78 days ago
    Change Detected
    Summary
    The two screenshots show formatting and UI adjustments only, with core study details such as eligibility criteria, interventions, primary outcomes, and listed locations unchanged.
    Difference
    0.3%
    Check dated 2025-11-03T13:52:46.000Z thumbnail image

Stay in the know with updates to Guselkumab vs Ustekinumab in Psoriasis Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Guselkumab vs Ustekinumab in Psoriasis Clinical Trial page.